A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies

1. De Wees W. Editorial comment. Philadelphia Journal of Medical and Physical Sciences 1825:207. Search in Google Scholar

2. Doubleday E. Case of uterine haemorrhage successfully treated by the operation of transfusion. Philadelphia Journal of Medical Physics 1825;54:380–6. Search in Google Scholar

3. Chapman JF, Elliott C, Knowles SM, et al. Guidelines for compatibility procedures in blood transfusion laboratories: British Committee for Standards in Haematology. Transfus Med 2004;14:50–73. Search in Google Scholar

4. AABB Standards Program Committee. Standards for immunohematology reference laboratories. 9th ed. Arlington, VA: AABB, 2016. Search in Google Scholar

5. U.S. Food and Drug Administration. Transfusion associated fatalities 2010–2014. Available from www.fda.gov. Accessed May 2017 Search in Google Scholar

6. Bolton-Maggs PHB, Cohen H. Serious Hazards of Transfusion (SHOT) haemovigilance and progress in improving transfusion safety. Br J Haematol 2013;1:1–12. Search in Google Scholar

7. Moncharmont P, Barday G, Py J-Y, et al. Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008–2013 national haemovigilance survey. Blood Transfus 2017;15:254–8. Search in Google Scholar

8. Leger R. In vitro cellular assays and other approaches used to predict the clinical significance of red cell alloantibodies: a review. Immunohematology 2002;18:65–70.10.21307/immunohematology-2019-512 Search in Google Scholar

9. Daniels G, Poole J, De Silva M, et al. The clinical significance of blood group antibodies. Transfus Med 2002;12:287–95.10.1046/j.1365-3148.2002.00399.x12383334 Search in Google Scholar

10. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21:58–71.10.1016/j.tmrv.2006.08.00317174221 Search in Google Scholar

11. Whitaker BI, Strong DM, Gandhi MJ, Petrisli E. Hemovigilance and the Notify Library. Immunohematology 2017;33:159–64.10.21307/immunohematology-2019-02334841819 Search in Google Scholar

12. Garratty G. The James Blundell Award Lecture 2007: Do we really understand immune red cell destruction. Transfus Med 2008:18;321–34.10.1111/j.1365-3148.2008.00891.x19140815 Search in Google Scholar

13. Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96–101.10.1159/000461705 Search in Google Scholar

14. Garratty G, Nance SJ. Correlation between in vivo hemolysis and the amount of red cell-bound IgG measured by flow cytometry. Transfusion 1990:30;617–21.10.1046/j.1537-2995.1990.30790385519.x2402775 Search in Google Scholar

15. Garratty G. Effect of cell-bound proteins on the in vivo survival of circulating blood cells. Gerontology 1991:37;68–94.10.1159/0002132522055500 Search in Google Scholar

16. Hadley AG. A comparison of in vitro tests for predicting the severity of hemolytic disease of the fetus and newborn. Vox Sang 1998;74:375–83.10.1111/j.1423-0410.1998.tb05445.x9704470 Search in Google Scholar

17. Hadley AG. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Clin Lab Haematol 1988;10:377–84.10.1111/j.1365-2257.1988.tb01184.x3150696 Search in Google Scholar

18. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev 1990;4:297–312.10.1016/S0887-7963(90)70272-6 Search in Google Scholar

19. Nance S, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449–52.10.1046/j.1537-2995.1987.27688071692.x3686653 Search in Google Scholar

20. Schanfield M, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies using human mononuclear phagocyte assay. Transfusion 1981;21:571–6.10.1046/j.1537-2995.1981.21582040822.x6794195 Search in Google Scholar

21. Zupanska B, Brijer E, McIntosh J, et al. Correlation of monocyte monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D. Vox Sang 1990;58:276–80.10.1111/j.1423-0410.1990.tb04999.x2399692 Search in Google Scholar

22. Mollison PL. Blood-group antibodies and red-cell destruction— II. Br Med J 1959:2:1123–30.10.1136/bmj.2.5160.1123199077114423434 Search in Google Scholar

23. Postoway N, Nance S, O’Neill P, Garratty G. Comparison of a practical differential agglutination procedure to flow cytometry in following the survival of transfused red cells. Transfusion 1985;25:453. Search in Google Scholar

24. Nance S, Scharberg EA, Thornton N, Yahalom V, Sareneva I, Lomas-Francis C. International rare donor panels: a review. Vox Sang 2016;110:209–18.10.1111/vox.1235726689301 Search in Google Scholar